首页> 美国卫生研究院文献>other >Combinatorial Co-Encapsulation of Hydrophobic Molecules in Poly(lactide-co-glycolide) Microparticles
【2h】

Combinatorial Co-Encapsulation of Hydrophobic Molecules in Poly(lactide-co-glycolide) Microparticles

机译:疏水性分子的组合共同封装在聚(丙交酯 - 共 - 乙交酯)的微粒

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

There is a great interest for developing poly(lactide-co-glycolide) (PLGA) based particles for targeted delivery and controlled release of encapsulated biological molecules. The PLGA particles can be used to deliver proteins, small molecule drugs and nucleotides. Furthermore, it has been shown that the co-encapsulation of multiple factors in PLGA particles generates synergistic responses, and can simultaneously provide theranostic benefits. However, the number of possible unique particle formulations that may be generated by the combination of different components in a particle increases dramatically with each new component, and currently, there is no method to generate such a vast library of unique PLGA particles. In order to address this gap, we have developed a high-throughput methodology to produce hundreds of small batches of particles. The particles are generated in the multi-well plate wells by a modified oil-in-water emulsion technique. In order to demonstrate the versatility of this technique, combinatorial formulations of six different loading concentrations of three fluorescent dyes were fabricated giving rise to 216 unique PLGA particle formulations. We demonstrate systematic and well-controlled combinatorial loading of hydrophobic molecules into the particles. This PPP methodology potentiates the generation of hundreds of different combinatorial particle formulations with multiple co-encapsulates in less than 24 h in standard polystyrene multi-well plates, thus providing rapid, low cost, high-throughput production. We envision that such a PPP library of particles encapsulating combinations of drugs and imaging modalities can subsequently be tested on small populations of cells in a high-throughput fashion, and provide personalized medicine.
机译:开发基于聚(丙交酯-共-乙交酯)(PLGA)的颗粒,用于靶向递送和控制释放包封的生物分子,引起了极大的兴趣。 PLGA颗粒可用于输送蛋白质,小分子药物和核苷酸。此外,已经表明在PLGA颗粒中共包封多种因子产生协同反应,并且可以同时提供治疗诊断学上的益处。但是,随着每种新成分的增加,可能由粒子中不同成分的组合产生的可能的独特粒子制剂的数量急剧增加,并且目前尚无方法生成如此庞大的独特PLGA粒子库。为了解决这一差距,我们开发了一种高通量方法,可生产数百个小批量的颗粒。通过改进的水包油乳化技术在多孔板孔中产生颗粒。为了证明该技术的多功能性,制造了六种不同上样浓度的三种荧光染料的组合制剂,从而产生了216种独特的PLGA颗粒制剂。我们证明了疏水分子到颗粒中的系统性和良好控制的组合加载。此PPP方法可在不到24小时内在标准聚苯乙烯多孔板中增强数百种具有多个共包封物的组合颗粒制剂的生成,从而提供快速,低成本,高通量的生产。我们设想,这种包裹药物和成像方式组合的颗粒的PPP库可以随后以高通量方式在小细胞群上进行测试,并提供个性化的药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号